ALUMIS INC.
ALMS$165M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOUTH SAN FRANCISCO
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Jul 1, 2026
15wMarket Overview
Stock performance and key metrics
ALMS News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Open-Label ESK-001
Plaque Psoriasis
ESK-001
Plaque Psoriasis
Apremilast
Plaque Psoriasis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Open-Label ESK-001 | Phase 3 | Plaque Psoriasis | - | - |
ESK-001 | Phase 3 | Plaque Psoriasis | - | - |
Apremilast | Phase 3 | Plaque Psoriasis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply